Carl Morris, Ph.D.

Carl Morris, Ph.D.

Former Chief Scientific Officer, NeuromuscularatSolid Biosciences· In proxies 2022–2023

Pay in FY2023+78% from the year before · Solid Biosciences stock +14.1% the same year

Carl Morris, Ph.D. was paid $1.6M in FY2023 (Dec), up 78%. Solid Biosciences stock rose 14.1% that year.

Pay$100 in the stock at the end of FY21 → $23
Pay is from the Summary Compensation Table of each Solid Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Solid BiosciencesPublic company · 4 yr
    • Former Chief Scientific Officer, Neuromuscular2022 – Present · 4 yrStock in role -77%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?